Medical Writing Authors and Authorship The sun never sets on transparency

Volume 25, Issue 1 - Authors and Authorship

The sun never sets on transparency


The financial relationships between the pharmaceutical and device industries and healthcare practitioners appear frequently in the spotlight because of their potential to create bias and influence prescribing choices. Public disclosure of these transactions may help patients make informed choices about their healthcare practitioners and may help reduce healthcare costs. The US Sunshine Act, a Federal law that requires disclosure of transactions between industry and healthcare practitioners, was passed in 2010. Similar disclosure laws and codes now exist globally. Unfortunately, none of the current requirements are clear about the reportability of industry support for medical writing and editorial services. Regardless, medical writers should be aware of these requirements, which can help them as they forge relationships with authors.

Download the full article


  1. Battisti WP, Wager E, Baltzer L, et al. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3Good Publication Practice for Company- Sponsored Research (GPP3). Annals of Internal Medicine. 2015;163(6): 461-464.
  2. ICMJE. Recommend at ions for the conduct, reporting, editing, and publication of scholarly work in medical journals. 2013; Available from:
  3. United States 111 Congress HR 3590. Patient protection and affordable care act. 2010:111-148.
  4. Centers for Medicare and Medicaid Services. Federal register. Department of Health and Human Services; 2013:9457-9528.
  5. Jarvies D, Coombes R, Stahl-Timmins W. Open Payments goes live with pharma to doctor fee data: first analysis. BMJ (Clinical research ed.). 2014-10- 01 16:46:40 2014;349.
  6. Morain SR, Flexner C, Kass NE, Sugarman J. Forecast for the Physician Payment Sunshine Act: Partly to Mostly Cloudy?Forecast for the Physician Payment Sunshine Act. Annals of Internal Medicine. 2014;161(12): 915-916.
  7. Centers for Medicare and Medicaid Services. CMS implements final rule change for open payments. In: Services CfMaM, ed. Vol Pubilc law no. 111- 152: Centers for Medicare and Medicaid Services; 2014.
  8. Andrews RE, Schwartz AY, Meehan P, et al. Final Sunshine Act letter to Marilyn Tavenner. 2014.
  9. Upton F. HR6-21st century cures act. 2015.
  10. Grassley C. S.213-Provider Payment Sunshine Act. 2015.
  11. Campbell DJ, Sharkey BP. Ready or not, full speed ahead for the global transparency movement. 2015; Available from:
  12. European Federation of Pharma ceut - ical Industries and Associations. EFPIA HCP/HCO disclosure code. 2014:1- 15.
  13. European Federation of Pharmaceutical Industries and Associations. EFPIA code on disclosure of transfers of value from pharma - ceutical companies to healthcare professionals and healthcare organisations: Frequently asked questions. 2014; Available from:–disclosure-code.pdf
  14. The International Society for Medical Publication Professionals. ISMPP Sunshine Act information update. 2014; Available from:
  15. Toroser D, DeTora L, Cairns A, et al. The Sunshine Act and medical publications: Guidance from professional medical associations. Postgrad Med. 2015/11/04 2015;127(7):752-757.
  16. Wechsler R, Hauser RA, French J, the Clinician Investigator C. Who is helping whom? Manuscript support and transfer of value. Annals of Neurology. 2015;77(2):353-355.
  17. Ratain MJ. Forecasting unanticipated consequences of “the Sunshine Act”: mostly cloudy. JCO. 2014;32(22): 2293-2295.



Authors and Authorship
Letter from the Editor
President’s Message
Ghostwriting prevalence among AMWA and EMWA members (2005 to 2014)
The sun never sets on transparency
GPP3 – what is it, why is it necessary and what is new?
Attribution, advocacy, disposable authors, corporate ghosts and cultural assimilation: new themes in the ethical critique of commercial medical literature
Perspective from a leading scientific author: An interview with Professor Ruth Roberts on authors and authoring
Authorship of clinical trial documents
Project management in medical publication writing: A less explored avenue in pharmaceutical companies and clinical research organisations
Never say never! Returning to full-time employment after freelancing
Fifth EMWA freelance business survey
Journal Watch
In the Bookstores
The Webscout
Regulatory Writing: Authorship issues in regulatory documents
English Grammar and Style
Medical Communication
Lingua Franca and Beyond
Gained in Translation
Medical Writing Teaching
Profile: An interview with Phil Leventhal
EMWA’s 2016 Webinar Programme
Out on our own


The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board


Raquel Billiones


Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Deputy Managing Editor

Alicia Brooks Waltman

Associate Editors

Anuradha Alahari

Jennifer Bell

Nicole Bezuidenhout

Claire Chang

Barbara Grossman

Sarah Milner

John Plant

Sampoorna Rappaz

Amy Whereat

Section Editors

Daniela Kamir


Jennifer Bell


Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News 

Ana Sofia Correia 

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh 

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Maddy Dyer


Lisa Chamberlain-James

Medical Communications/Writing for Patients

Payal Bhatia

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Adriana Rocha


Tiziana von Bruchhausen


Clare ChangZuo Yen Lee 

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Louisa Ludwig-Begall / Sarah Kabani

The Crofter: Sustainable Communications

Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Layout Designer

Chris Monk